The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 25, 2025

Filed:

Apr. 29, 2022
Applicants:

Muhammed Majeed, Bangalore, IN;

Kalyanam Nagabhushanam, East Windsor, NJ (US);

Sarang Bani, Bangalore, IN;

Anjali Pandey, Bangalore, IN;

Inventors:

Muhammed Majeed, Bangalore, IN;

Kalyanam Nagabhushanam, East Windsor, NJ (US);

Sarang Bani, Bangalore, IN;

Anjali Pandey, Bangalore, IN;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/12 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); A61K 47/10 (2017.01); A61K 47/12 (2006.01); A61K 47/22 (2006.01); A61K 47/26 (2006.01); A61K 47/42 (2017.01); A61P 5/00 (2006.01); A61P 5/14 (2006.01); A61P 5/24 (2006.01);
U.S. Cl.
CPC ...
A61K 31/12 (2013.01); A61K 9/0056 (2013.01); A61K 9/1617 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/4866 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61K 47/42 (2013.01); A61P 5/00 (2018.01); A61P 5/14 (2018.01); A61P 5/24 (2018.01);
Abstract

The invention discloses compositions comprising bisdemethoxycurcumin and methods for managing polycystic ovary syndrome (PCOS) and its associated conditions which include hormonal imbalance, obesity, hypothyroidism, hyperandrogenism, oxidative stress, inflammation, gut dysbiosis, hypercholesterolemia, cardiovascular complications, hyperglycemia and insulin resistance. The invention also discloses the potential of a curcuminoid composition comprising 20-80% w/w bisdemethoxycurcumin, 10-35% w/w demethoxycurcumin and 10-50% w/w curcumin for use in the therapeutic management of PCOS.


Find Patent Forward Citations

Loading…